Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Slaughter

Showing results (291-300 of 338) with videos related to

Pageof 34
Sort By:
Journal of Cardiac Failure|January 24, 2025
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial AnalysisGabriel Sayer, Mustafa M Ahmed, Mandeep R Mehra, et al.
Circulation|September 12, 2012
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonanceAtul R Chugh, Garth M Beache, John H Loughran, et al.
Journal of the American College of Cardiology|April 24, 2010
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patientsJoseph G Rogers, Keith D Aaronson, Andrew J Boyle, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 14, 2011
Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device supportRalph J Petrucci, Joseph G Rogers, Laura Blue, et al.
JACC. Heart Failure|April 11, 2015
Reply: Upgrade ambulatory extra-aortic counterpulsation to full-support LVADWilliam T Abraham, Sanjeev Aggarwal, Sumanth D Prabhu, et al.
JACC. Heart Failure|October 11, 2014
Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failureWilliam T Abraham, Sanjeev Aggarwal, Sumanth D Prabhu, et al.
Heart Rhythm O2|January 6, 2022
Implantable cardioverter-defibrillator-related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experienceAshwin Ravichandran, Naga Venkata K Pothineni, Jaimin R Trivedi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist DeviceScott C Silvestry, Claudius Mahr, Mark S Slaughter, et al.
Journal of the American Heart Association|June 3, 2022
Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist DeviceRakesh Gopinathannair, Naga Venkata K Pothineni, Jaimin R Trivedi, et al.
Journal of the American College of Cardiology|March 12, 2014
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)Ulrich P Jorde, Sudhir S Kushwaha, Antone J Tatooles, et al.
Pageof 34

Showing results (291-300 of 338) with videos related to

Sort By:
Pageof 34
Journal of Cardiac Failure|January 24, 2025
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial AnalysisGabriel Sayer, Mustafa M Ahmed, Mandeep R Mehra, et al.
Circulation|September 12, 2012
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonanceAtul R Chugh, Garth M Beache, John H Loughran, et al.
Journal of the American College of Cardiology|April 24, 2010
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patientsJoseph G Rogers, Keith D Aaronson, Andrew J Boyle, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 14, 2011
Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device supportRalph J Petrucci, Joseph G Rogers, Laura Blue, et al.
JACC. Heart Failure|April 11, 2015
Reply: Upgrade ambulatory extra-aortic counterpulsation to full-support LVADWilliam T Abraham, Sanjeev Aggarwal, Sumanth D Prabhu, et al.
JACC. Heart Failure|October 11, 2014
Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failureWilliam T Abraham, Sanjeev Aggarwal, Sumanth D Prabhu, et al.
Heart Rhythm O2|January 6, 2022
Implantable cardioverter-defibrillator-related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experienceAshwin Ravichandran, Naga Venkata K Pothineni, Jaimin R Trivedi, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist DeviceScott C Silvestry, Claudius Mahr, Mark S Slaughter, et al.
Journal of the American Heart Association|June 3, 2022
Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist DeviceRakesh Gopinathannair, Naga Venkata K Pothineni, Jaimin R Trivedi, et al.
Journal of the American College of Cardiology|March 12, 2014
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)Ulrich P Jorde, Sudhir S Kushwaha, Antone J Tatooles, et al.
Pageof 34